Mesa Laboratories, Inc. Reports Earnings Results for the Fourth Quarter and Full Year Ended March 31, 2024
June 05, 2024 at 11:00 am
Share
Mesa Laboratories, Inc. reported earnings results for the fourth quarter and full year ended March 31, 2024. For the fourth quarter, the company reported sales was USD 58.9 million compared to USD 55.59 million a year ago. Net loss was USD 254.58 million compared to net income of USD 0.611 million a year ago. Basic loss per share from continuing operations was USD 47.2 compared to basic earnings per share from continuing operations of USD 0.11 a year ago. Diluted loss per share from continuing operations was USD 47.2 compared to diluted earnings per share from continuing operations of USD 0.11 a year ago.
For the full year, sales was USD 216.19 million compared to USD 219.08 million a year ago. Net loss was USD 254.25 million compared to net income of USD 0.93 million a year ago. Basic loss per share from continuing operations was USD 47.2 compared to basic earnings per share from continuing operations of USD 0.17 a year ago. Diluted loss per share from continuing operations was USD 47.2 compared to diluted earnings per share from continuing operations of USD 0.17 a year ago.
Mesa Laboratories, Inc. designs and manufactures life sciences tools and critical quality control solutions for regulated applications in the pharmaceutical, healthcare, and medical device industries. Its segments include Sterilization and Disinfection Control, Clinical Genomics, Biopharmaceutical Development, and Calibration Solutions. Sterilization and Disinfection Control segment manufactures and sells biological, chemical and cleaning indicators. It also provides testing and laboratory services, mainly to the dental and pharmaceutical industries. Clinical Genomics segment develops, manufactures and sells genetic analysis tools and related consumables and services. Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. Calibration Solutions segment develops, manufactures, sells and services quality control products. It has manufacturing operations in the United States and Europe.